Renal mitochondria response to sepsis: a sequential biopsy evaluation of experimental porcine model.
Summary
In a randomized porcine fecal peritonitis model with sequential renal biopsies, high-severity sepsis caused an early decrease in oxidative phosphorylation and increased uncoupling that preceded macro-hemodynamic changes and coincided with rises in serum creatinine. Renal medulla exhibited lower mitochondrial capacity than cortex, and PGC-1α was reduced in high-severity animals. These data suggest severity-dependent mitochondrial endotypes in sepsis-induced AKI.
Key Findings
- High-severity sepsis caused decreased oxidative phosphorylation and increased uncoupling within 24 hours, preceding renal macro-hemodynamic changes.
- Serum creatinine rose early, indicating renal dysfunction not primarily driven by hemodynamics.
- Renal medulla had lower oxidative phosphorylation and ETS activity than cortex; PGC-1α decreased in high-severity animals.
Clinical Implications
Renal dysfunction in severe sepsis may be driven by early mitochondrial failure rather than macro-hemodynamics, supporting early mitochondrial-targeted diagnostics and therapies (e.g., biogenesis enhancers) and suggesting phenotype-specific trial designs for SA-AKI.
Why It Matters
This large-animal, sequential tissue study reconciles conflicting preclinical findings by showing early, severity-dependent mitochondrial dysfunction that is independent of macro-hemodynamics, reframing SA-AKI mechanisms.
Limitations
- Small sample size (n=15) and open-label design in a single preclinical model
- Short observation window (~24 h) limits assessment of longer-term renal recovery or fibrosis
Future Directions
Define SA-AKI mitochondrial endotypes prospectively in humans, test mitochondrial biogenesis/uncoupling modulators, and integrate renal regional oxygenation imaging with bioenergetic biomarkers.
Study Information
- Study Type
- RCT
- Research Domain
- Pathophysiology
- Evidence Level
- IV - Randomized preclinical (animal) experiment; not a human clinical trial.
- Study Design
- OTHER